Cite

HARVARD Citation

    Cohen, R. et al. (2020). The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data. Journal of Crohn's and colitis. pp. 192-204. [Online]. 
  
Back to record